Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Drug treatment strategies for depression in Parkinson disease
Melody Ryan, Courtney V. Eatmon, John T. Slevin
Expert Opinion on Pharmacotherapy (2019) Vol. 20, Iss. 11, pp. 1351-1363
Closed Access | Times Cited: 83

Showing 1-25 of 83 citing articles:

Parkinson’s disease: etiopathogenesis and treatment
Joseph Jankovic, Eng King Tan
Journal of Neurology Neurosurgery & Psychiatry (2020) Vol. 91, Iss. 8, pp. 795-808
Open Access | Times Cited: 808
The Biology and Pathobiology of Glutamatergic, Cholinergic, and Dopaminergic Signaling in the Aging Brain
Anna Gąsiorowska, Małgorzata Wydrych, Patrycja Drapich, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 118
Neurobiology of depression in Parkinson’s disease: Insights into epidemiology, molecular mechanisms and treatment strategies
Mir Hilal Ahmad, M. Moshahid A. Rizvi, Mansoor Ali, et al.
Ageing Research Reviews (2023) Vol. 85, pp. 101840-101840
Closed Access | Times Cited: 62
The Noradrenergic System in Parkinson’s Disease
Elena Paredes-Rodriguez, Sergio Vegas‐Suárez, Teresa Morera‐Herreras, et al.
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 107
Depression and type 2 diabetes: A causal relationship and mechanistic pathway
Wael Y. Khawagi, Hayder M. Al‐kuraishy, Nawar R. Hussein, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 8, pp. 3031-3044
Open Access | Times Cited: 16
Drug Choices and Advancements for Managing Depression in Parkinson's Disease
Francesca Assogna, Clelia Pellicano, Cinzia Savini, et al.
Current Neuropharmacology (2019) Vol. 18, Iss. 4, pp. 277-287
Open Access | Times Cited: 58
Neuroprotective Potency of Saffron Against Neuropsychiatric Diseases, Neurodegenerative Diseases, and Other Brain Disorders: From Bench to Bedside
Yaqi Bian, Chen Zhao, Simon Ming‐Yuen Lee
Frontiers in Pharmacology (2020) Vol. 11
Open Access | Times Cited: 58
Berberine Protects Against NLRP3 Inflammasome via Ameliorating Autophagic Impairment in MPTP-Induced Parkinson’s Disease Model
Shuxuan Huang, Hanqun Liu, Yuwan Lin, et al.
Frontiers in Pharmacology (2021) Vol. 11
Open Access | Times Cited: 55
A selective NLRP3 inflammasome inhibitor attenuates behavioral deficits and neuroinflammation in a mouse model of Parkinson's disease
Shuxuan Huang, Zhi Chen, Binglin Fan, et al.
Journal of Neuroimmunology (2021) Vol. 354, pp. 577543-577543
Closed Access | Times Cited: 46
Parkinson and depression: review and outlook
Gerd Laux
Journal of Neural Transmission (2022) Vol. 129, Iss. 5-6, pp. 601-608
Closed Access | Times Cited: 33
Depression in Major Neurodegenerative Diseases and Strokes: A Critical Review of Similarities and Differences among Neurological Disorders
Javier Pagonabarraga, Cecilio Álamo, Mar Castellanos, et al.
Brain Sciences (2023) Vol. 13, Iss. 2, pp. 318-318
Open Access | Times Cited: 23
A systematic review of the associations between sedentary behavior, physical inactivity, and non-motor symptoms of Parkinson’s disease
Aiza Khan, Joy Ezeugwa, Victor E. Ezeugwu
PLoS ONE (2024) Vol. 19, Iss. 3, pp. e0293382-e0293382
Open Access | Times Cited: 7
Similarities Between Depression and Neurodegenerative Diseases: Pathophysiology, Challenges in Diagnosis and Treatment Options
Madiha Hussain, Prabhat Kumar, Sara Khan, et al.
Cureus (2020)
Open Access | Times Cited: 42
Mood Disorders and Anxiety in Parkinson’s Disease: Current Concepts
Hendrik Lintel, Timothy Corpuz, Saif-ur-Rahman Paracha, et al.
Journal of Geriatric Psychiatry and Neurology (2021) Vol. 34, Iss. 4, pp. 280-288
Closed Access | Times Cited: 36
Depression in Parkinson's Disease: A Narrative Review
Rahul Chikatimalla, Thejaswi Dasaradhan, Jancy Koneti, et al.
Cureus (2022)
Open Access | Times Cited: 23
Pharmacological and Non-Pharmacological Treatments for Depression in Parkinson’s Disease: An Updated Review
Efthalia Angelopoulou, Evangelia Stanitsa, Claire Chrysanthi Karpodini, et al.
Medicina (2023) Vol. 59, Iss. 8, pp. 1454-1454
Open Access | Times Cited: 14
Depression and Parkinson’s disease
E. R. Bukhurova, B. A. Alipkhanova, D. Z. Shanibova, et al.
Vestnik nevrologii psihiatrii i nejrohirurgii (Bulletin of Neurology Psychiatry and Neurosurgery) (2024), Iss. 8, pp. 982-991
Closed Access | Times Cited: 6
Association of Baseline Depression and Anxiety with Longitudinal Health Outcomes in Parkinson's Disease
Yiwen Shi, Roseanne D. Dobkin, Daniel Weintraub, et al.
Movement Disorders Clinical Practice (2024) Vol. 11, Iss. 9, pp. 1103-1112
Open Access | Times Cited: 5
Treatment of Nonmotor Symptoms Associated with Parkinson Disease
Jennifer G. Goldman, Carlos M. González Guerra
Neurologic Clinics (2020) Vol. 38, Iss. 2, pp. 269-292
Closed Access | Times Cited: 34
Focus on Depression in Parkinson’s Disease: A Delphi Consensus of Experts in Psychiatry, Neurology, and Geriatrics
Luis Agüera-Ortíz, R. García-Ramos, Francisco J. Grandas Pérez, et al.
Parkinson s Disease (2021) Vol. 2021, pp. 1-11
Open Access | Times Cited: 32
Mitochondria targeting fluorescent probe for MAO-A and the application in the development of drug candidate for neuroinflammation
Jia‐Rong Wu, Chaoyan Han, Xudong Cao, et al.
Analytica Chimica Acta (2022) Vol. 1199, pp. 339573-339573
Closed Access | Times Cited: 22
Novel HDAC inhibitors provide neuroprotection in MPTP-induced Parkinson's disease model of rats
Sai Teja Meka, Sree Lalitha Bojja, Gautam Kumar, et al.
European Journal of Pharmacology (2023) Vol. 959, pp. 176067-176067
Closed Access | Times Cited: 13
Antidepressants and type 2 diabetes: highways to knowns and unknowns
Nahi Sabih Alruwaili, Hayder M. Al‐kuraishy, Ali I. Al‐Gareeb, et al.
Diabetology & Metabolic Syndrome (2023) Vol. 15, Iss. 1
Open Access | Times Cited: 12
Effect of Transcranial Direct Current Stimulation (tDCS) on Depression in Parkinson’s Disease—A Narrative Review
James Chmiel, Filip Rybakowski, Jerzy Leszek
Journal of Clinical Medicine (2024) Vol. 13, Iss. 3, pp. 699-699
Open Access | Times Cited: 4
Monoamine Oxidase Inhibitors: From Classic to New Clinical Approaches
Pablo Duarte, Antonio Cuadrado, Rafael León
Handbook of experimental pharmacology (2020), pp. 229-259
Closed Access | Times Cited: 32
Page 1 - Next Page

Scroll to top